Glycated Albumin to Predict Adverse Neonatal Outcomes among Women with Diabetes and Overweight or Obese Body Mass Index.
Jennifer Powers CarsonJyoti AroraEbony CarterPublished in: The journal of applied laboratory medicine (2024)
In this pilot study, % GA shows promise to stratify pregnant patients with diabetes and obesity into risk categories for ANO with excellent predictive ability in the second trimester. If this holds in larger studies, using second trimester % GA could allow additional intervention to improve blood glucose control and minimize ANO.
Keyphrases
- blood glucose
- weight loss
- glycemic control
- pet ct
- body mass index
- weight gain
- type diabetes
- bariatric surgery
- preterm birth
- pregnancy outcomes
- gestational age
- randomized controlled trial
- metabolic syndrome
- insulin resistance
- pregnant women
- physical activity
- adipose tissue
- big data
- cardiovascular disease
- case control
- blood pressure
- high fat diet induced
- artificial intelligence